- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 2 x SO4: SULFATE ION(Non-functional Binders)
SO4.4: 4 residues within 4Å:- Chain A: F.17, Q.21, H.141
- Chain B: K.158
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:Q.21
- Salt bridges: A:H.141, B:K.158
SO4.7: 2 residues within 4Å:- Chain B: Q.21, H.141
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:Q.21
- Salt bridges: B:H.141, A:K.158
- 2 x AHD: 4-AMINO-1-HYDROXYBUTANE-1,1-DIYLDIPHOSPHONATE(Non-covalent)
AHD.5: 14 residues within 4Å:- Chain A: D.98, D.102, R.107, Q.167, K.207, T.208, Y.211, Q.247, D.250, K.264
- Ligands: MG.1, MG.2, MG.3, IPE.6
9 PLIP interactions:9 interactions with chain A- Hydrogen bonds: A:R.107, A:R.107, A:K.207, A:K.207, A:Q.247, A:D.250, A:K.264, A:K.264
- Water bridges: A:S.104
AHD.11: 14 residues within 4Å:- Chain B: D.98, D.102, R.107, Q.167, K.207, T.208, Y.211, Q.247, D.250, K.264
- Ligands: MG.8, MG.9, MG.10, IPE.12
15 PLIP interactions:15 interactions with chain B- Hydrogen bonds: B:D.98, B:D.98, B:R.107, B:R.107, B:K.207, B:Y.211, B:Q.247, B:K.264, B:K.264
- Water bridges: B:D.102, B:D.102, B:D.102, B:S.104, B:D.254, B:D.254
- 2 x IPE: 3-METHYLBUT-3-ENYL TRIHYDROGEN DIPHOSPHATE(Non-covalent)
IPE.6: 16 residues within 4Å:- Chain A: G.47, K.48, Y.49, R.51, Q.91, R.108, T.208, Y.211, T.212, F.246, Q.247, D.250, K.264, R.360, K.362
- Ligands: AHD.5
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:T.208, A:F.246
- Hydrogen bonds: A:K.48, A:Y.49, A:Q.91, A:R.360
- Salt bridges: A:R.51, A:R.108, A:K.264, A:K.362, A:K.362
IPE.12: 15 residues within 4Å:- Chain B: G.47, K.48, R.51, Q.91, R.108, T.208, Y.211, T.212, F.246, Q.247, D.250, K.264, R.360, K.362
- Ligands: AHD.11
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:T.208, B:F.246, B:D.250
- Hydrogen bonds: B:K.48, B:Q.91, B:Q.91, B:R.360
- Salt bridges: B:R.51, B:R.108, B:K.264, B:K.362, B:K.362
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gabelli, S.B. et al., Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: Implications for drug design. Proteins (2005)
- Release Date
- 2005-12-20
- Peptides
- farnesyl pyrophosphate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x MG: MAGNESIUM ION(Non-covalent)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- 2 x AHD: 4-AMINO-1-HYDROXYBUTANE-1,1-DIYLDIPHOSPHONATE(Non-covalent)
- 2 x IPE: 3-METHYLBUT-3-ENYL TRIHYDROGEN DIPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gabelli, S.B. et al., Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: Implications for drug design. Proteins (2005)
- Release Date
- 2005-12-20
- Peptides
- farnesyl pyrophosphate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B